Homocysteine Levels in Type 2 Diabetic Patients with Nephropathy and Coronary Artery Disease
Journal Title: Turkish Journal of Endocrinology and Metabolism - Year 2003, Vol 7, Issue 4
Abstract
The aim of the study was to investigate the relationship between plasma homocysteine (Hcy) levels and diabetic vascular complications and family history of diabetes mellitus (DM) and coronary artery disease (CAD) in patients with type 2 diabetes. Fasting plasma total Hcy concentrations and uncomplicated[metabolic parameters were investigated in 116 diabetic patients patients (n = 35), patients with nephropathy (n = 41), patients with CAD (n = and 31 healthy control subjects. Family histories of DM and CAD of the]40) patients were also studied. The plasma Hcy levels were significantly higher in 2.9± 6.5 vs. 9.6 ±the diabetic patients than in the control subjects (12.9 mol/l, Pμ<0.001). There were no differences between uncomplicated diabetic ± 3.5 vs. 9.6 ± patients and control subjects with respect to Hcy levels (9.60.05). The nephropathy group had higher Hcy levels than the>mol/l, Pμ2.9 mol/l, Pμ 3.5 ± 8.8 vs. 9.6 ±uncomplicated group (14.6 <0.05). Similarly, CAD ± 5.5 vs. 9.6±group had higher Hcy levels than the uncomplicated group (13.3 0.05). Hcy did not correlate with lipid parameters and metabolic<mol/l, Pμ3.5 control of diabetes. There was a significant relationship between hyperhomocysteinemia and family history of CAD of patients (38% vs. 12%, P=0.01). The findings suggest that elevated plasma Hcy levels are strongly associated with nephropathy and coronary artery disease in patients with type 2 diabetes. Also the relationship between hyperhomocysteinemia and a positive family history of CAD found in this study suggests that genetic predisposition may be more responsible for the unfavourable effects of hyperhomocysteinemia in macrovascular complications.
Authors and Affiliations
Alev Altınova, İlhan Yetkin, Esen Akbay, Füsun Törüner, Reyhan Ersoy, Ayhan Karakoç, Göksun Ayvaz, Nuri Çakır, Metin Arslan
Keywords
Related Articles
- EP ID EP84422
- DOI -
- Views 121
- Downloads 0
The Levels of Serum High Sensitivity C-reactive Protein in Subjects with Impaired Fasting Glucose
High-sensitivity C-reactive protein is a well-known risk factor for cardiovascular heart diseases. In this study we aimed to determine the levels of serum high-sensitivity Creactive protein in patients with newly diagnos...
Effects of Dexfenfluramine on Body Weight, Fat Distribution and Lipid Profile in Patients with Obesity
Body weight (BW), body fat ratio (BFR) and serum lipid profile were evaluated in 50 obese patients; 20 treated with a 1100Kcal Standard low calorie diet (group D) and 30 treated with dexfenfluramine (DF) along with the s...
Subclinical Autonomous Glucocorticoid Hypersecretion
Subclinical autonomous glucocorticoid hypersecretion (SAGH) occurs in patients who have clinically nonfunctioning adrenal adenomas when cortisol secretion becomes autonomous and dysregulated, not fully restrained by pitu...
Correlation of Increased Lipid Peroxidation with Serum Gonadotropins and Testosterone Levels in Type 2 Diabetic Men with Erectile Dysfunction
Hypogonadotropic hypogonadism is one of cause in the pathogenesis of erectile dysfunction (ED) in type 2 diabetic men. Oxidative stress has been defined an important factor associated with the complications of diabetes (...
The Effects of Body Mass Index on the Cardiovascular Risk Factors in the Patients with Essential Hypertension
To examine effects of body mass index on cardiovascular risk factors in hypertensive women. Study Design: Retrospective, cross-sectional study Subjects: 446 hypertensive subjects attending the endocrinology outpatient Me...